S'abonner

Efficacy of bilateral catheter superficial parasternal intercostal plane blocks using programmed intermittent bolus for opioid-sparing postoperative analgesia in cardiac surgery with sternotomy: A randomized, double-blind, placebo-controlled trial - 25/04/24

Doi : 10.1016/j.jclinane.2024.111430 
Qi Li a, 1 , Yi Liao a, 1 , Xiaoe Wang a , Mingying Zhan b , Li Xiao a, , 2 , Yu Chen a, 2, ⁎⁎
a Department of Anesthesiology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China 
b Department of Anesthesiology, Guangdong Provincial People's Hospital, Guangzhou, China 

Correspondence to: L. Xiao, Department of Anesthesiology, The First Affiliated Hospital of Sun Yat-sen University, No. 58, Zhongshan 2nd Road, Guangzhou 510080, China.Department of AnesthesiologyThe First Affiliated Hospital of Sun Yat-sen UniversityNo. 58, Zhongshan 2nd RoadGuangzhou510080China⁎⁎Correspondence to: Y. Chen, Department of Anesthesiology, The First Affiliated Hospital of Sun Yat-sen University, No. 58, Zhongshan 2nd Road, Guangzhou 510080, China.Department of AnesthesiologyGuangdong Provincial People's Hospital106 Zhongshan 2nd RoadGuangzhouGuangdong ProvinceChina

Abstract

Study objective

This study investigated whether catheter superficial parasternal intercostal plane (SPIP) blocks, using a programmed intermittent bolus (PIB) with ropivacaine, could reduce opioid consumption while delivering enhanced analgesia for a period exceeding 48 h following cardiac surgery involving sternotomy.

Design

A double-blind, prospective, randomized, placebo-controlled trial.

Setting

University-affiliated tertiary care hospital.

Patients

60 patients aged 18 or older, scheduled for cardiac surgery via sternotomy.

Interventions

The patients were randomly assigned in a 1:1 ratio to either the ropivacaine or saline group. After surgery, patients received bilateral SPIP blocks for 48 h with 0.4% ropivacaine (20 mL per side) for induction, followed by bilateral SPIP catheters using PIB with 0.2% ropivacaine (8 mL/side, interspersed with a 2-h interval) or 0.9% normal saline following the same administration schedule. All patients were administered patient-controlled analgesia with hydromorphone.

Measurements

The primary outcome was the cumulative morphine equivalent consumption during the initial 48 h after the surgery. Secondary outcomes included postoperative pain assessment using the Numeric Rating Scale (NRS) at rest and during coughing at designated intervals for three days post-extubation. Furthermore, recovery indicators and ropivacaine plasma levels were diligently documented.

Main results

Cumulative morphine consumption within 48 h in ropivacaine group decreased significantly compared to saline group (25.34 ± 31.1 mg vs 76.28 ± 77.2 mg, respectively; 95% CI, −81.9 to −20.0, P = 0.002). The ropivacaine group also reported lower NRS scores at all recorded time points (P < 0.05) and a lower incidence of nausea and vomiting than the saline group (3/29 vs 12/29, respectively; P = 0.007). Additionally, the ropivacaine group showed significant improvements in ambulation (P = 0.018), respiratory exercises (P = 0.006), and self-reported analgesia satisfaction compared to the saline group (P = 0.016).

Conclusions

Bilateral catheter SPIP blocks using PIB with ropivacaine reduced opioid consumption over 48 h, concurrently delivering superior postoperative analgesia in adult cardiac surgery with sternotomy.

Le texte complet de cet article est disponible en PDF.

Highlights

Postoperative pain after cardiac surgery is challenging.
Catheter superficial parasternal intercostal plane blocks using a programmed intermittent bolus regimen reduced the morphine equivalent requirement up to three days after surgery.
The technique also reduces the incidence of postoperative nausea and vomiting, facilitating postoperative recovery.

Le texte complet de cet article est disponible en PDF.

Keywords : Superficial parasternal intercostal plane block catheters, Programmed intermittent bolus, Opioid-sparing analgesia, Postoperative pain, Cardiac surgery


Plan


© 2024  The Authors. Publié par Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 95

Article 111430- août 2024 Retour au numéro
Article précédent Article précédent
  • Effects of esketamine on postoperative negative emotions and early cognitive disorders in patients undergoing non-cardiac thoracic surgery: A randomized controlled trial
  • Tianyuan Luo, Zhimin Deng, Qiyang Ren, Fangfang Mu, You Zhang, Haiying Wang
| Article suivant Article suivant
  • General anesthesia is not associated with dementia in older adults with osteoarthritis for hip/knee replacements, a national population-based nested case-control study
  • Yuting Lin, Chun-Chia Chen, Chen Dong, Yu-Ze Luan, Jing-Yang Huang, James Cheng-Chung Wei, Jeng-Yuan Chiou

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.